Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rina Kitada

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Cancer Research Communications|September 19, 2025
Functional Analysis of Rare RAS Variants of Unknown SignificanceSoohwan Park, Masachika Ikegami, Rina Kitada, et al.
Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association|November 19, 2024
Analysis of cancer multigene panel testing for osteosarcoma in pediatric and adults using the center for cancer genomics and advanced therapeutics database in JapanYoshiyuki Suehara, Rina Kitada, Satoshi Kamio, et al.
The Journal of Bone and Joint Surgery. American Volume|May 27, 2026
Differences Among Genomic Profiling Tests for Bone and Soft-Tissue Sarcomas in a Universal Health Insurance SystemSatoshi Kamio, Masachika Ikegami, Rina Kitada, et al.
Human Molecular Genetics|February 6, 2008
R-spondin1 plays an essential role in ovarian development through positively regulating Wnt-4 signalingKazuma Tomizuka, Kaori Horikoshi, Rina Kitada, et al.
NPJ Breast Cancer|October 4, 2024
Cancer risk assessment of premalignant breast tissues from patients with BRCA mutations by genome profilingTakeshi Hirose, Masachika Ikegami, Kumiko Kida, et al.
Cancer Science|July 30, 2025
Discovery of Novel RASGRF2 Fusions as a Therapeutic Target in Lung Adenocarcinoma of Never or Light SmokersYuki Terashima, Soohwan Park, Hiroshi Ikeuchi, et al.
Journal of Neuro-Oncology|February 16, 2024
The development of a custom RNA-sequencing panel for the identification of predictive and diagnostic biomarkers in gliomaYukina Shirai, Toshihide Ueno, Shinya Kojima, et al.
Japanese Journal of Clinical Oncology|November 9, 2025
Analysis of comprehensive genomic profiling test for Ewing sarcoma in pediatric patients and adults using the nationwide clinical and genomic database in JapanSatoshi Kamio, Koichi Ogura, Yoshiyuki Suehara, et al.
Oncogene|September 13, 2024
Correction: GLI1 confers resistance to PARP inhibitors by activating the DNA damage repair pathwayHiroshi Ikeuchi, Yusuke Matsuno, Rika Kusumoto-Matsuo, et al.
Oncogene|August 2, 2024
GLI1 confers resistance to PARP inhibitors by activating the DNA damage repair pathwayHiroshi Ikeuchi, Yusuke Matsuno, Rika Kusumoto-Matsuo, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Cancer Research Communications|September 19, 2025
Functional Analysis of Rare RAS Variants of Unknown SignificanceSoohwan Park, Masachika Ikegami, Rina Kitada, et al.
Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association|November 19, 2024
Analysis of cancer multigene panel testing for osteosarcoma in pediatric and adults using the center for cancer genomics and advanced therapeutics database in JapanYoshiyuki Suehara, Rina Kitada, Satoshi Kamio, et al.
The Journal of Bone and Joint Surgery. American Volume|May 27, 2026
Differences Among Genomic Profiling Tests for Bone and Soft-Tissue Sarcomas in a Universal Health Insurance SystemSatoshi Kamio, Masachika Ikegami, Rina Kitada, et al.
Human Molecular Genetics|February 6, 2008
R-spondin1 plays an essential role in ovarian development through positively regulating Wnt-4 signalingKazuma Tomizuka, Kaori Horikoshi, Rina Kitada, et al.
NPJ Breast Cancer|October 4, 2024
Cancer risk assessment of premalignant breast tissues from patients with BRCA mutations by genome profilingTakeshi Hirose, Masachika Ikegami, Kumiko Kida, et al.
Cancer Science|July 30, 2025
Discovery of Novel RASGRF2 Fusions as a Therapeutic Target in Lung Adenocarcinoma of Never or Light SmokersYuki Terashima, Soohwan Park, Hiroshi Ikeuchi, et al.
Journal of Neuro-Oncology|February 16, 2024
The development of a custom RNA-sequencing panel for the identification of predictive and diagnostic biomarkers in gliomaYukina Shirai, Toshihide Ueno, Shinya Kojima, et al.
Japanese Journal of Clinical Oncology|November 9, 2025
Analysis of comprehensive genomic profiling test for Ewing sarcoma in pediatric patients and adults using the nationwide clinical and genomic database in JapanSatoshi Kamio, Koichi Ogura, Yoshiyuki Suehara, et al.
Oncogene|September 13, 2024
Correction: GLI1 confers resistance to PARP inhibitors by activating the DNA damage repair pathwayHiroshi Ikeuchi, Yusuke Matsuno, Rika Kusumoto-Matsuo, et al.
Oncogene|August 2, 2024
GLI1 confers resistance to PARP inhibitors by activating the DNA damage repair pathwayHiroshi Ikeuchi, Yusuke Matsuno, Rika Kusumoto-Matsuo, et al.
Pageof 2